MIDTERMS: Gastrointestinal Drugs Flashcards
Mechanism of Action of Antacids
Neutralize hydrochloric acid (HCl) to form salt and water. Carbon dioxide (CO2) is produced by some antacids like calcium carbonate and sodium bicarbonate.
Drug Interactions with Antacids
Inhibit absorption of tetracycline, ciprofloxacin, ketoconazole, digoxin, iron
Enhance absorption of levodopa
Enhance renal excretion of quinidine, amphetamine
Common PPIs
Dexlansoprazole, esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole.
: Common Antacids and Their Reactions
Aluminum hydroxide: Al(OH)3 + 3 HCl → AlCl3 + 3 H2O
Magnesium hydroxide: Mg(OH)2 + 2 HCl → MgCl2 + 2 H2O
Calcium carbonate: CaCO3 + 2 HCl → CaCl2 + H2O + CO2
Sodium bicarbonate: NaHCO3 + HCl → NaCl + H2O + CO2
Clinical Uses of Antacids
Transient dyspepsia, heartburn, peptic ulcer disease (PUD), gastritis.
Adverse Effects of Antacids
Magnesium salts: Osmotic diarrhea
Aluminum salts: Constipation
Systemic: Belching, flatulence, metabolic alkalosis, hypercalcemia, milk-alkali syndrome
Potential link to Alzheimer’s Disease
Common H2 Receptor Blockers
Cimetidine, ranitidine, nizatidine, famotidine.
Adverse Effects of PPIs
Diarrhea, abdominal pain, headache, muscle pain, fatigue, rash, risk for respiratory infections, pneumonia, and Clostridium difficile infection.
Mechanism of Action of H2 Receptor Blockers
Prevent histamine-activated release of gastric acid under basal conditions and food stimulation.
Clinical Uses of H2 Receptor Blockers
Peptic ulcer, dyspepsia, gastroesophageal reflux disease (GERD).
Clinical Uses of PPIs
Gastric and duodenal ulcers, GERD, non-ulcer dyspepsia, Zollinger-Ellison syndrome, prevention of stress-related mucosal bleeding.
Mechanism and Use of Sucralfate
Forms a protective gel that adheres to ulcers, preventing erosion and aiding healing. Side effect: constipation.
Adverse Effects of H2 Receptor Blockers
CNS effects (dizziness, somnolence, headache), endocrine effects (gynecomastia, galactorrhea), blood dyscrasias (granulocytopenia, thrombocytopenia), liver toxicity (cholestasis, hepatitis).
Mechanism of Action of PPIs
Irreversibly bind to H+-K+ ATPase in acid medium, inhibiting gastric acid secretion (85-95%).
First-Line Triple Therapy for H. pylori
Two antibacterials (amoxicillin and clarithromycin or metronidazole and clarithromycin) plus one PPI.